By Ogheneruona Ajuyasono

Big Data Analytics (BDA) is increasingly regarded as a crucial mechanism for improving the performance, quality and efficiency of healthcare systems. New technologies such as electronic health records (EHRs), patient-generated data, medical devices, administrative data and other electronic sources have provided unprecedented opportunities to derive new insights from healthcare data. In the United Kingdom, where the National Health Service (NHS) is under constant financial and operational strain, the capability to process and synthesize expansive matrices, complex datasets into useful information is especially valuable. Available evidence suggests that BDA can be used in clinical decisions, disease prediction, resource allocation, patient monitoring and service planning, as well as improve results and reduce unnecessary expenditure (Khanra et al., 2020; Batko & Ślęzak, 2021).

In this article we look at the opportunities BDA can provide in changing the face of healthcare and reducing costs in the UK. Based on the systematic literature review done by Ajuyasono (2023), as well as other literature, it focuses on three interconnected areas: the role of analytics in clinical and operational decision-making, the opportunities for efficiency and control of healthcare costs, and the technological, organizational and governance challenges to its value. The literature shows that the usefulness of BDA does not only lie in having a lot of data. Instead, benefits rely on the quality, interoperability and availability of data and the analytical and organizational processes that make information into decisions (Wang et al. 2018; Wang & Alexander 2019).

The analysis shows that BDA presents a major opportunity for the NHS, but does not necessarily provide a technological ‘automatic solution’ to the ever-increasing costs of healthcare. To effectively implement digital infrastructure requires interoperability, reliable data, appropriate analytical skills, effective governance, and organizational readiness to integrate evidence into clinical and managerial practice. The UK healthcare system, therefore, will depend less on the amount of data gathered by BDA than on the NHS’s capabilities to formulate economically significant, expeditious and credible decisions based on the information that BDA provides.

Digitization: Data in Healthcare Systems

Data has become a central component of healthcare systems as digitisation has transformed how patient information is created, stored, and shared. The totality of electronic health records, diagnostic systems, wearable devices, medical imaging, administrative records and patient-generated data generates information that is too vast for traditional analytical methods to handle. However, Big Data is also unique by its velocity, variety, veracity and value (Laney, 2001; Chen & Zhang, 2014). In the medical field, this poses both a challenge and an opportunity: Large amounts of data can be used to discern patterns that cannot be seen in individual clinical interactions, but mining meaningful knowledge out of the data requires the ability to combine and analyze information with the appropriate technology.

The potential impact on the United Kingdom is significant. The NHS creates huge amounts of data from primary care, secondary care, prescribing, diagnostics, patient records and administration systems. When properly incorporated, these data can support more accurate risk assessment, timely disease diagnosis, patient monitoring, and better allocation of health care resources. Krumholz (2014) posited that the high volume of health information at a large scale opens up new possibilities of personalized treatment, prevention and better evidence-based decision-making. In the same way, Wang et al., (2018) show that BDA ability can be a catalyst for change in the healthcare sector, and Khanra et al., (2020) through a systematic review illustrate that analytics in healthcare has evolved in various application areas, such as clinical decision-making, disease prediction and healthcare management.

The economic argument is also of major importance. The cost of the treatment is not just the cost of the treatment; it is also a result of inefficient use of resources, delay in treatment, avoidable hospitalizations and inappropriate use of services and administrative inefficiencies. By analyzing patterns of demand and utilization, analytics can help healthcare organizations predict demand and optimize resource allocation. According to a review of research done by Ajuyasono (2023), BDA can contribute to the quality of healthcare services from the following aspects: decision support, forecasting, interoperability, traceability, and improved analytical capability. Such benefits, however, rely on the ability of healthcare organizations to translate analytical products into action.

The question is not whether sufficient healthcare data are available, but whether the available data can be converted into reliable knowledge and economically sound decision-making. Several studies have indicated prolonged challenges related to data quality, interoperability, privacy and information security, infrastructure, and lack of key staff (Awrahman et al., 2022; Batko & Ślęzak, 2021; Kruse et al., 2016). There is added complexity in the UK context as information is created by various organizations and at different points in the patient pathway. This article therefore examines BDA’s impact on outcomes and cost savings across three dimensions: clinical and operational improvement; efficiency and cost control; and obstacles to achieving sustainable value in the context of BDA.

Big Data Analytics and Improved Healthcare Outcomes

Evidence-based decision-making

A primary application for BDA is the shift from reactive to predictive and evidence-based healthcare decision making. Healthcare organizations can harness the historical and real-time data to uncover patterns related to disease, patient deterioration, treatment response, and service demand. Predictive analytics can thus help clinicians and managers to anticipate problems before they escalate into more serious and resource-consuming issues. Krumholz (2014) contends that big data in health care could aid in better prediction of how patients will react to therapeutic interventions, earlier diagnoses and more systematic comparison of treatments. Likewise, Wu et al. (2016) show how analytics and wearable technologies can be used to assist in healthcare decision-making and patient monitoring.

How BDA Supports Disease Prediction

The literature also indicates that BDA can be used to support disease prediction and personalized healthcare. Medical data can be integrated with demographic, behavior and physical measurements to enable models to detect patterns in patient groups. The reviewed literature cited by Ajuyasono (2023) shows that the significant application areas discussed are disease prediction, patient monitoring, and diagnostic frameworks and risk profiling. This is especially true if early intervention will prevent deterioration and minimize the severity of later treatment. Predictiveness is not the same as clinical effectiveness, however. Van Calster et al. (2019) point out that there is a need for validation, not just in the healthcare sector, but for the predictive models themselves, to be sure that they actually work reliably and provide an advantage for patients, as sophisticated models do not equate to improved outcomes.

Optimizing Operations with Data

BDA also holds value beyond direct clinical decision-making. Healthcare institutions can leverage data to optimize operations, such as scheduling, resource planning, patient flow, and resource utilization. Wang et al. (2021) demonstrates that BDA capability can help to enhance the quality of care in specific configurations of the organization, highlighting that analytical technology is valuable when it is aligned with certain organizational capabilities. This helps to emphasize another important model: BDA is not just a piece of software, it’s a capacity of the organization. It will only be effective in improving NHS outcomes if analytical information is effective in supporting the use of NHS clinical, managerial and technical teams within their current processes.

Big Data Analytics, Efficiency and Healthcare Cost Reduction

Effective Use of Resources for patient intervention

The economic argument for BDA is mainly based on its ability to decrease inefficiencies of technology, not just the cost. When resources are not used effectively, demand is inaccurately predicted, or patients do not receive necessary treatment and interventions at the opportuned juncture, healthcare costs can increase. Analytics can also help determine utilization patterns and help with forecasting to ensure resources are available when needed. Wang and Hajli (2017) conceptualize a relationship between the capabilities of BDA and organizational value, and Wang et al. 2018 claim that analytics can play a role in enabling transformation by linking technological capability with organizational processes.

Predictive analytics is especially relevant when it comes to cost management, as early identification and intervention can help minimize the resource burden of advanced disease. Likewise, a system of surveillance of large populations could lead to the identification of high-risk individuals who may need specific interventions. Ajuyasono (2023) found a systematic association between BDA and better forecasting, faster decision making, traceability and interoperability that can be helpful for better healthcare resource management. The dissertation also shows how BDA could help improve the prediction model creation for UK healthcare organizations in order to enhance diagnosis and treatment.

Operational Efficiency and Cost Reduction

Another way to reduce costs is through operational efficiency. Waiting times, patient flows and service utilization and resource requirements may be analyzed on large datasets. Descriptive analytics helps explain what has occurred. Predictive analytics helps anticipate what may occur. Prescriptive analytics helps decision-makers understand the options available for responding. Thus, the distinction is significant because analytical insights can be used to influence resource allocation and operational practices to achieve cost savings, rather than simply generating additional reports. According to Batko and Ślęzak (2021), BDA can be used in various aspects of healthcare, such as clinical, managerial or technological.

The association of BDA and cost reduction, however, must be looked at with caution. Some investments are needed to implement analytics: infrastructure, data integration, cyber security, specialized staff, organizational change. Therefore, an organization could actually spend more money in the beginning, and then see results. However, according to Wang and Alexander (2019), challenges related to data quality, system responsiveness and the selection of analytical technologies are issues that must be addressed by the healthcare organization. Thus, the value of BDA should be measured by its ability to provide measurable clinical and operational value over time and not based on the assumption that digitalization alone brings about savings.

Data Quality, Interoperability and Governance as Conditions for Value

Big Data Vs Good Data

The value of healthcare BDA largely depends on the quality of the data on which analytical models rely. Big data does not necessarily equal good data. Patient information inaccuracies, inconsistent terminology, duplicated information and errors can compromise analytical results. Data quality is cited as an ongoing issue in Ajuyasono’s (2023) review, as information from the electronic health record, personal health records and other sources can also have inaccuracies that can impact the reliability of the analyses. Increasing the volume of data without increasing the quality of data may lead to more uncertainty not less.

Interoperability is a related challenge. Data from healthcare organizations, platforms and clinical systems is often created in various formats. The analytical value of data is lost when such systems fail to communicate to each other effectively. Interoperability and EHR adoption are critical concerns, according to Kruse et al. (2016), about healthcare technology implementation. The UK literature also identifies challenges to linking information at various touchpoints along the patient journey. So interoperability is not just a technical challenge for an NHS looking to achieve system-wide benefits, it’s a requirement to create a clear picture of patients, populations and service demand.

Privacy and Security in Data Gathering

Finally, the proliferation of BDA mediates many complex privacy, security, consent, and governance-related concerns. The data healthcare providers collate comprises very sensitive personal data; hence, the value of analysis has to be weighed against the protection of patient rights. Privacy and security are among the most tenacious challenges to healthcare BD as identified in the literature (Awrahman et al., 2022). The UK and European regulators, notably under the auspices of the General Data Protection Regulation, have focused more attention on the lawful and responsible processing of health information. Therefore, effective governance must facilitate legitimate data uses and maintain public trust. Without trust, even the most technically advanced analytics could encounter institutional skepticism from practitioners and patients alike.

Conclusion

Improving Healthcare Outcomes and Delivery

The United Kingdom has a significant opportunity to employ Big Data Analytics to improve healthcare outcomes and augment the efficiency of service delivery by the NHS. Its main value is that it allows healthcare organizations to shift from working on a reactive basis to become more predictive, evidence-based and data-driven when making decisions. The usage of the analytical capability in the fields of disease prediction, patient monitoring, clinical decision support, forecasting and resource allocation show how it can enhance clinical and operational performance.

But the economic advantages aren’t quite as pronounced. BDA has the potential to reduce costs through earlier intervention, better use of resources, minimization of inefficiencies and better operational planning, but these cost savings are reliant on the quality of the data being used and the ability of organizations to act on the information provided by analysis. The findings of the systematic study conducted by Joy Ajuyasono provide evidence of significant opportunities and persistent challenges of infrastructure, data quality, skills, interoperability, privacy and security.

Finally, it is not enough for the NHS to have more data, it must have ‘controlled, interoperable and analytically useful data’.” So therefore, the strategic added value of BDA is likely to stem from incorporating technology, organizational capability, professional skills and responsible governance. Under these circumstances, analytics can be a crucial tool in enhancing patient outcomes and managing costs. In their absence, the collection of large amounts of data might end up being a costly technological endeavor with little clinical and economic usefulness.

Author’s Profile

Ogheneruona Ajuyasono is a professional technology expert and IT Project Manager with extensive years of delivering software, systems implementation and business transformation enabled by technology.

References

Ajuyasono, O. J. (2023). Review of Big Data Analytics to Improve Healthcare System Outcomes and Reduce Costs in the United Kingdom. MSc dissertation, University of Derby.Awrahman, B. J., et al. (2022).

A review of the role and challenges of big data in healthcare informatics and analytics. Journal of Healthcare Engineering, 2022, 5317760. https://doi.org/10.1155/2022/5317760

Batko, K., & Ślęzak, A. (2021). The use of Big Data Analytics in healthcare. Journal of Big Data, 8, 133. https://doi.org/10.1186/s40537-021-00553-4

Chen, C. P., & Zhang, C.-Y. (2014). Data-intensive applications, challenges, techniques and technologies: A survey on Big Data. Information Sciences, 275, 314–347. https://doi.org/10.1016/j.ins.2014.01.015

Khanra, S., Dhir, A., Islam, A. N., & Mäntymäki, M. (2020). Big data analytics in healthcare: A systematic literature review. Enterprise Information Systems, 14(7), 878–912. https://doi.org/10.1080/17517575.2020.1812005

Krumholz, H. M. (2014). Big data and new knowledge in medicine: The thinking, training, and tools needed for a learning health system. Health Affairs, 33(7), 1163–1170. https://doi.org/10.1377/hlthaff.2014.0053

Kruse, C. S., Kothman, K., Anerobi, K., & Abanaka, L. (2016). Adoption factors of the electronic health record: A systematic review. JMIR Medical Informatics, 4(2), e19. https://doi.org/10.2196/medinform.5525

Laney, D. (2001). 3D Data Management: Controlling Data Volume, Velocity and Variety. META Group.

Van Calster, B., McLernon, D. J., van Smeden, M., Wynants, L., & Steyerberg, E. W. (2019). Calibration: The Achilles heel of predictive analytics. BMC Medicine, 17, 230. https://doi.org/10.1186/s12916-019-1466-7

Wang, L., & Alexander, C. A. (2019). Big data analytics in healthcare systems. International Journal of Mathematical, Engineering and Management Sciences, 4(1), 17–26. https://doi.org/10.33889/IJMEMS.2019.4.1-002

Wang, Y., & Hajli, N. (2017). Exploring the path to big data analytics success in healthcare. Journal of Business Research, 70, 287–299.

Wang, Y., Kung, L., & Byrd, T. A. (2018). Big data analytics: Understanding its capabilities and potential benefits for healthcare organizations. Technological Forecasting and Social Change, 126, 3–13. https://doi.org/10.1016/j.techfore.2015.12.019

Wang, Y., Kung, L., Gupta, S., & Ozdemir, S. (2021). Leveraging Big Data Analytics to improve quality of care in healthcare organisations: A configurational perspective. British Journal of Management. https://doi.org/10.1111/1467-8551.12332

Wu, J., Wang, H., Cheng, S., & Lin, Z. (2016). The promising future of healthcare services: When Big Data Analytics meets wearable technology. Information & Management, 53(8), 1020–1033.